Showing results (71-80 of 325) with videos related to
Sort By:
Pageof 33
Thrombosis Research|August 15, 1989
Comparative pharmacology of low molecular weight heparins: implications of manufacturing processes on biological effectsC Doutremepuich, M Guyot, M C Lalanne, et al.Thrombosis Research|April 15, 1987
Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challengesJ M Walenga, M Petitou, J C Lormeau, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 25, 2000
Soluble P-selectin in human plasma: effect of anticoagulant matrix and its levels in patients with cardiovascular disordersH M Amin, S Ahmad, J M Walenga, et al.Seminars in Thrombosis and Hemostasis|January 1, 1993
Postoperative monitoring of low molecular weight heparin prophylaxis in high-risk patientsP Bacher, B Horst, H G Breyer, et al.Investigative Radiology|February 1, 1995
Flow cytometric evaluation of platelet activation by ionic or nonionic contrast media and modulation by heparin and recombinant hirudinM J Koza, T C Shankey, J M Walenga, et al.Seminars in Thrombosis and Hemostasis|January 1, 1995
Evaluation of hemostatic and fibrinolytic alterations associated with daily administration of low-molecular-weight heparin for a 12-week periodB Lojewski, P Bacher, O Iqbal, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
Use of recombinant hirudin to increase the patency rate of microanastomosis in a rabbit modelT Hubbard, T Olivier, P Bacher, et al.Seminars in Thrombosis and Hemostasis|January 1, 1985
Studies on the antithrombotic effects and pharmacokinetics of heparin fractions and fragmentsJ Fareed, J M Walenga, K Williamson, et al.Seminars in Thrombosis and Hemostasis|October 1, 1984
Molecular markers of contrast media-induced adverse reactionsJ Fareed, R Moncada, H L Messmore, et al.Thrombosis Research|May 1, 1992
The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis modelP Bacher, D Welzel, O Iqbal, et al.Pageof 33